Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Ellis

Showing results (91-100 of 285) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST StudyMatthew J Ellis, Antonio Llombart-Cussac, David Feltl, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2016
Increased Dead Space Ventilation Mediates Reduced Exercise Capacity in Systolic Heart FailureKirk Kee, Christopher Stuart-Andrews, Matthew J Ellis, et al.
Breast Cancer Research and Treatment|August 10, 2006
The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancersP Kelly Marcom, Claudine Isaacs, Lyndsay Harris, et al.
Cancer Biology & Therapy|March 17, 2004
Estrogen receptor expression and sensitivity to paclitaxel in breast cancerMichele K Dougherty, Lisa M Schumaker, V Craig Jordan, et al.
European Journal of Preventive Cardiology|June 20, 2018
The prognostic significance of chronotropic incompetence in patients with severe left ventricular systolic function referred for cardiac transplant assessmentHitesh C Patel, Shaun Yo, Shane Nanayakkara, et al.
Breast Cancer Research and Treatment|October 23, 2008
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trialMatthew J Ellis, William R Miller, Yu Tao, et al.
AJR. American Journal of Roentgenology|January 23, 2016
Application of a Novel CT-Based Iliac Artery Calcification Scoring System for Predicting Renal Transplant OutcomesBradley Davis, Daniele Marin, Lynne M Hurwitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2011
Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsivenessNyam-Osor Chimge, Sanjeev K Baniwal, Jingqin Luo, et al.
Clinical Proteomics|October 25, 2023
Mass spectrometry quantifies target engagement for a KRASG12C inhibitor in FFPE tumor tissueAndrew G Chambers, David C Chain, Steve M Sweet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2022
Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)Vera J Suman, Lili Du, Tanya Hoskin, et al.
Pageof 29

Showing results (91-100 of 285) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST StudyMatthew J Ellis, Antonio Llombart-Cussac, David Feltl, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2016
Increased Dead Space Ventilation Mediates Reduced Exercise Capacity in Systolic Heart FailureKirk Kee, Christopher Stuart-Andrews, Matthew J Ellis, et al.
Breast Cancer Research and Treatment|August 10, 2006
The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancersP Kelly Marcom, Claudine Isaacs, Lyndsay Harris, et al.
Cancer Biology & Therapy|March 17, 2004
Estrogen receptor expression and sensitivity to paclitaxel in breast cancerMichele K Dougherty, Lisa M Schumaker, V Craig Jordan, et al.
European Journal of Preventive Cardiology|June 20, 2018
The prognostic significance of chronotropic incompetence in patients with severe left ventricular systolic function referred for cardiac transplant assessmentHitesh C Patel, Shaun Yo, Shane Nanayakkara, et al.
Breast Cancer Research and Treatment|October 23, 2008
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trialMatthew J Ellis, William R Miller, Yu Tao, et al.
AJR. American Journal of Roentgenology|January 23, 2016
Application of a Novel CT-Based Iliac Artery Calcification Scoring System for Predicting Renal Transplant OutcomesBradley Davis, Daniele Marin, Lynne M Hurwitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2011
Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsivenessNyam-Osor Chimge, Sanjeev K Baniwal, Jingqin Luo, et al.
Clinical Proteomics|October 25, 2023
Mass spectrometry quantifies target engagement for a KRASG12C inhibitor in FFPE tumor tissueAndrew G Chambers, David C Chain, Steve M Sweet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2022
Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)Vera J Suman, Lili Du, Tanya Hoskin, et al.
Pageof 29